Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03334292 · ClinicalTrials.gov registry record
Natural History of Wilson Disease
A clinical trial of Wilson Disease, sponsored by Yale University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 6
- Study locations
NCT03334292: Recruiting study of Wilson Disease, sponsored by Yale University.
NCT03334292 is a study of Wilson Disease that is actively recruiting participants, run by Yale University. The registered enrollment target is 300 participants, above the 52-participant average among 4 other Wilson Disease trials with a reported enrollment target (477% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03334292, a study of Wilson Disease, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product utilization and development.
Primary Outcome
This outcome is a binary 'yes/no' outcome as to whether or not this study can successfully create a repository with the intent to store data and specimens to support the conduct of future research on Wilson disease.
Conditions Studied
Study Locations (6)
Connecticut
- Yale University - New Haven
Florida
- Advent Health - Orlando
Texas
- Baylor College of Medicine - Houston
Washington
- Seattle Children's Hospital - Seattle
Other
- Universitätsklinikum Heidelberg - Heidelberg
Surrey
- Royal Surrey Country Hospital - Guildford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2029-11-15 |
What NCT03334292 shows while recruiting
NCT03334292 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 52-participant average among 4 other Wilson Disease trials with a reported enrollment target (477% higher).
The record links to 1 condition, with Wilson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03334292 lists 6 locations in 6 states (Connecticut, Florida, Texas).
Frequently Asked Questions
What is clinical trial NCT03334292 about?
NCT03334292 is a clinical study titled "Natural History of Wilson Disease". The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product util...
What is the current status of trial NCT03334292?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2017-12-18. Estimated completion is 2029-11-15.
What conditions does trial NCT03334292 study?
This clinical trial studies the following conditions: Wilson Disease.
Who is sponsoring clinical trial NCT03334292?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03334292 being conducted?
This trial has 6 study locations across Connecticut, Florida, Texas, Washington, Surrey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wilson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
RECRUITING
-
Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study
RECRUITING
-
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
ACTIVE NOT RECRUITING · Phase 1
-
The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI